- Bitmovin

PhD video research: From the ATHENA lab to Bitmovin products

Introduction The story of Bitmovin began with video research and innovation back in 2012, when our co-founders Stefan Lederer and Christopher Mueller were students at Alpen-Adria-Universität (AAU) Klagenfurt. Together with their professor Dr. Christian Timmerer, the three co-founded Bitmovin in 2013, with their research providing the foundation for Bitmovin’s groundbreaking MPEG-DASH player and Per-Title Encoding….

how to improve qoe featured image

How to Improve Viewers’ Quality of Experience (QoE) While Cutting Storage and Delivery costs (ft. Teleport Media)

This article was a collaborative article written by Bitmovin & Teleport Media | Authors: Andrei Klimenko, CEO, Teleport Media & Joshua Shulman, Content Marketer, Bitmovin Streamed content is the future of video viewing. With that in mind, the quality of the video content and the viewers’ quality of experience (QoE) become key success factors for…

Quality of Experience for MPEG-DASH

QoE with High Definition Video Through Adaptive Streaming with MPEG-DASH – 3

This is the third and final part of our series on high quality video streaming where we discuss the results of our experiments, our findings and conclusions that can be drawn from the data, particularly in relation to adaptive streaming with MPEG-DASH. Experimental Results The average media throughput in terms of bitrate [kbps] is shown in Figure 3….

- Bitmovin

QoE with High Definition Video Through Adaptive Streaming with MPEG-DASH – 1

This is part one of a three part series analysing the impact of Adaptive Streaming, specifically MPEG-DASH, on Quality of Experience (QoE). Real-time entertainment services such as high quality video streaming currently account for more than 60% of the Internet traffic, e.g., in North America’s fixed access networks as shown in Figure 1. Interestingly, these…

Join the 50k+ companies, developers and professionals who access our latest news and insights.

The Bitmovin Blog. Keeping you informed.

Join the conversation